UNSPSC 51283962: Mesulfamide

This classification denotes an antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y19VNL22L0. European Medicines Agency schedules Mesulfamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08794MIG. Mesulfamide generally arises in the molecular formula C7H10N2O5S2.

The term MESULFAMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, volume 33, no. 10 1979, list 19.) MESULFAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S(=O)(=O)(N)C1CCC(NCS(=O)(=O)O)CC1.

UNSPSC 51283962 Mesulfamide is a Commodity code that in practice covers pharmaceutical products and related medical supplies procured by state and local health agencies, though recent state and local opportunities under this code show minimal direct alignment with the mesulfamide specification itself. Instead, jurisdictions are using this code to tag acquisitions of commonly needed pharmaceutical inventory—including antibiotics, opioid antagonists, and drug deactivation systems—through both direct purchase and piggyback agreements with established pharmaceutical suppliers. The issuing bodies soliciting under the code are primarily state health departments and county health or community services agencies managing public health stockpiles and emergency response inventories.

Recent activity clusters in Illinois and Florida. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse cooperative purchasing consortium to Chartwell Rx LLC on August 28, 2026 for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets, totaling $2,999,999.11 over the initial 12-month term plus renewal options for years 2 and 3; this was an Invitation for Bid with response due September 11, 2026. Seminole County, Florida issued an IFB (IFB60459723LAS) posted June 30, 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford and a response deadline of July 26, 2023. Both procurements emphasize volume purchasing, fixed pricing, and compliance with drug-free workplace and E-Verify requirements.